D-2Health

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Agency: Department of Health and Human Services
Run by: National Institutes of Health
Target applicants: Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, City or township governments, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), State governments, Native American tribal governments (Federally rec
Application period: 2024-11-25 ~ 2026-11-17
Contact: National Institutes of Health 301-402-2541

Open in EDIT and start the application View on Grants.gov Application site

Source: Grants.gov

How to apply

Register your organization on SAM.gov to get a UEI (Unique Entity ID). It can take up to 10 business days to become active, and it must be renewed every year. SAM.gov
Create a Grants.gov account and add an applicant profile with your UEI. The E-Business Point of Contact named in SAM.gov gives the person who submits the AOR role. Grants.gov
On the opportunity page, select Apply to create a Workspace. Complete the SF-424 and the other required forms in Workspace. Opportunity page
Attach the narrative documents the NOFO asks for (such as the Project Narrative, Project Abstract and Budget Justification) in Workspace. EDIT can draft them from your materials. Workspace
Submit from Workspace, then check the status with your Grants.gov tracking number. Track my application

Overview

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD and that (2) interventions for FASD. These objectives will be accomplished with the Exploratory/Developmental Phased Award (R61/R33) mechanism, clinical trial optional. The R61 phase will support pilot studies or secondary data analysis for hypothesis development and feasibility, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R61 phase. Highest priority will be given to applications with clinical trials. Applicants interested in planning clinical trials or adding to current projects may also consider NOFO (TEMP-23832, the R34 option). Opportunity number: PAR-25-158 Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.